Clearbridge Investments LLC trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 13.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,060,026 shares of the company’s stock after selling 328,366 shares during the quarter. Clearbridge Investments LLC’s holdings in HealthEquity were worth $197,659,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Arcadia Investment Management Corp MI acquired a new position in shares of HealthEquity in the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC boosted its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares in the last quarter. UMB Bank n.a. boosted its stake in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares in the last quarter. Skandinaviska Enskilda Banken AB publ grew its holdings in shares of HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after purchasing an additional 445 shares during the last quarter. Finally, Lindbrook Capital LLC increased its stake in shares of HealthEquity by 27.6% in the fourth quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock valued at $72,000 after buying an additional 162 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.
HealthEquity Stock Down 2.1 %
Shares of NASDAQ:HQY opened at $86.96 on Monday. The company has a 50 day moving average price of $103.63 and a two-hundred day moving average price of $96.21. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market capitalization of $7.52 billion, a PE ratio of 79.78, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59.
Analyst Ratings Changes
View Our Latest Analysis on HealthEquity
Insider Activity
In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.20% of the stock is owned by company insiders.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- How to invest in marijuana stocks in 7 steps
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- What is a Bond Market Holiday? How to Invest and Trade
- MarketBeat Week in Review – 03/24 – 03/28
- 3 Warren Buffett Stocks to Buy Now
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.